Evive Biotech Technographics
Evive Biotech Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Evive Biotech and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 47 Evive Biotech employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Evive Biotech has purchased the following applications: VNET ABUS for Subscription and Recurring Billing in 2023, Microsoft 365 for Collaboration in 2020, DocuSign eSignature for Digital Signing in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Evive Biotech is running and its propensity to invest more and deepen its relationship with VNET Group , Microsoft , DocuSign or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Evive Biotech revenues, which have grown to $5.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Evive Biotech intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Evive Biotech Tech Stack and Enterprise Applications
Evive Biotech ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| VNET Group | Legacy | VNET ABUS | Subscription and Recurring Billing | ERP | n/a | 2023 | 2023 |
In 2023 Evive Biotech deployed VNET ABUS from VNET Group on its corporate website to manage subscription workflows, adopting the application for Subscription and Recurring Billing functions. The implementation is surfaced on the public site and is referenced in source documentation as 21Vianet Group ABUS, and VNET ABUS is the primary billing platform recorded for recurring revenue management.
The VNET ABUS deployment focuses on core Subscription and Recurring Billing capabilities including subscription lifecycle management, recurring invoice generation, billing schedule configuration, and customer-facing subscription management. Configuration work emphasized plan definitions, billing cycles, proration rules, and automated invoicing templates to align with the companys product and pricing structures.
Operational coverage centers on website-driven customer signups and the finance and revenue operations functions, with the billing engine embedded into checkout and subscription flows on the public site. The deployment uses VNET ABUS as the billing orchestration layer, enabling synchronized subscription state, invoice issuance, and automated billing events without disclosed third party payment integrations.
Governance and process adjustments concentrated on centralizing billing responsibilities within finance, establishing subscription approval and change workflows, and defining access control for subscription and invoice management. Rollout details documented a web-first integration approach, and ongoing operational ownership sits with Evive Biotech finance and revenue operations teams.
|
Evive Biotech Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2020 | 2020 |
|
Evive Biotech Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
|
Evive Biotech IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Evive Biotech
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Evive Biotech Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||